P3 Health Partners Inc. Income Statement
PIII|4 years of annual SEC 10-K data (FY2021-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 4 fiscal years. All figures from audited SEC 10-K filings.
P3 Health Partners Inc. reported $1.5B in revenue and $136M in net loss for FY2024. Revenue has grown at a 117.7% compound annual rate over the past 3 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $1.5B | $1.0B | $578.6M | $145.5M |
| SG&A Expense | $112.6M | $157.3M | $100.2M | $36.4M |
| Operating Income | -$320.7M | -$1.6B | -$129.1M | -$39.5M |
| Interest Expense | -$22.2M | -$11.4M | -$9.8M | -$2.5M |
| Income Tax | $4.4M | $1.9M | $1.9M | $0 |
| Net Income | -$135.8M | -$270.1M | -$146.4M | -$42.0M |
| EPS (Basic) | -$46.78 | -$6.50 | -$6.50 | -$0.24 |
| EPS (Diluted) | -$54.06 | -$6.50 | -$6.50 | -$0.24 |
| Shares Outstanding | 2.9M | 41.6M | 41.6K | 41.6M |
| Operating Margin | -21.4% | -148.7% | -22.3% | -27.2% |
| Profit Margin | -9.0% | -25.7% | -25.3% | -28.8% |